AB-Biotics S.A. | Mutual Funds
Mutual Funds that own AB-Biotics S.A.
Bona-Renda, FI
100,000
0.79%
0
3.44%
12/31/2017
Norfeu Renta 24, SICAV
90,661
0.72%
-31,720
16.79%
03/31/2018
Oportunidad Bursatil, SICAV
40,088
0.32%
0
1.23%
12/31/2017
Penta Inversión, FI
15,000
0.12%
0
0.67%
12/31/2017
Bankia Dividendo España, FI
14,165
0.11%
-4,369
0.07%
12/31/2017
Report Inversiones, SICAV
11,167
0.09%
0
1.35%
12/31/2017
Eurobolsa Selección, SICAV
9,300
0.07%
-100
0.41%
12/31/2017
Attitude Opportunities, FI
8,475
0.07%
0
0.04%
03/31/2018
Annualcycles Strategies, FI
3,946
0.03%
3,946
0.16%
12/31/2017
Valdecarros 2000, SICAV
0
0%
-2,750
0%
12/31/2017
| Address |
Esade Creapolis
Barcelona Catalonia 08172
Spain
|
|
Employees
|
- |
| Website |
http://www.ab-biotics.com |
| Updated |
07/08/2019 |
| AB-Biotics SA engages in the research, development, innovation, and production of biotechnological solutions. It operates through the Probiotics and Genetic Tests business areas. The Probiotics business area offers probiotics for cardiometabolic, oral care, pediatrics, gastrointestinal health, gynaecology and urology, and dermatology and immunology. |
